메뉴 건너뛰기




Volumn 64, Issue 3, 2012, Pages 604-608

Hepatitis C virus-related cryoglobulinemic vasculitis: Emerging trends in therapy

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; BOCEPREVIR; CORTICOSTEROID; CRYOGLOBULIN; CYCLOPHOSPHAMIDE; PEGINTERFERON ALPHA; PREDNISONE; RIBAVIRIN; RITUXIMAB; TELAPREVIR; VIRUS RNA;

EID: 84857694125     PISSN: 00043591     EISSN: 15290131     Source Type: Journal    
DOI: 10.1002/art.34326     Document Type: Review
Times cited : (5)

References (30)
  • 1
    • 0013920228 scopus 로고
    • Cryoglobulinemia-a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability
    • Meltzer M, Franklin EC,. Cryoglobulinemia-a study of twenty-nine patients. I. IgG and IgM cryoglobulins and factors affecting cryoprecipitability. Am J Med 1966; 40: 828-36.
    • (1966) Am J Med , vol.40 , pp. 828-836
    • Meltzer, M.1    Franklin, E.C.2
  • 2
    • 0016262898 scopus 로고
    • Biologic and clinical significance of cryoglobulins: A report of 86 cases
    • Brouet JC, Clauvel JP, Danon F, Klein M, Seligmann M,. Biologic and clinical significance of cryoglobulins: a report of 86 cases. Am J Med 1974; 57: 775-88.
    • (1974) Am J Med , vol.57 , pp. 775-788
    • Brouet, J.C.1    Clauvel, J.P.2    Danon, F.3    Klein, M.4    Seligmann, M.5
  • 3
    • 0024509701 scopus 로고
    • Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral genome
    • Choo QL, Kuo G, Weiner AJ, Overby LR, Bradley DW, Houghton M,. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral genome. Science 1989; 244: 359-62.
    • (1989) Science , vol.244 , pp. 359-362
    • Choo, Q.L.1    Kuo, G.2    Weiner, A.J.3    Overby, L.R.4    Bradley, D.W.5    Houghton, M.6
  • 5
    • 12044257541 scopus 로고
    • Interferon-α in mixed cryoglobulinemic patients: A randomized, crossover, controlled trial
    • Ferri C, Marzo E, Longombardo G, Lombardini F, La Civita L, Vanacore R, et al. Interferon-α in mixed cryoglobulinemic patients: a randomized, crossover, controlled trial. Blood 1993; 81: 1132-6.
    • (1993) Blood , vol.81 , pp. 1132-1136
    • Ferri, C.1    Marzo, E.2    Longombardo, G.3    Lombardini, F.4    La Civita, L.5    Vanacore, R.6
  • 6
    • 0027997788 scopus 로고
    • Natural interferon-α versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: A long-term, randomized, controlled study
    • Dammacco F, Sansonno D, Han JH, Shyamala V, Cornacchiulo V, Iacobelli AR, et al. Natural interferon-α versus its combination with 6-methyl-prednisolone in the therapy of type II mixed cryoglobulinemia: a long-term, randomized, controlled study. Blood 1994; 84: 3336-43.
    • (1994) Blood , vol.84 , pp. 3336-3343
    • Dammacco, F.1    Sansonno, D.2    Han, J.H.3    Shyamala, V.4    Cornacchiulo, V.5    Iacobelli, A.R.6
  • 8
    • 0036899329 scopus 로고    scopus 로고
    • Interferon-α and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis
    • Cacoub P, Lidove O, Maisonobe T, Duhaut P, Thibault V, Ghillani P, et al. Interferon-α and ribavirin treatment in patients with hepatitis C virus-related systemic vasculitis. Arthritis Rheum 2002; 46: 3317-26.
    • (2002) Arthritis Rheum , vol.46 , pp. 3317-3326
    • Cacoub, P.1    Lidove, O.2    Maisonobe, T.3    Duhaut, P.4    Thibault, V.5    Ghillani, P.6
  • 9
    • 33750945860 scopus 로고    scopus 로고
    • Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemic vasculitis: A long-term followup study
    • Saadoun D, Resche-Rigon M, Thibault V, Piette JC, Cacoub P,. Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemic vasculitis: a long-term followup study. Arthritis Rheum 2006; 54: 3696-706.
    • (2006) Arthritis Rheum , vol.54 , pp. 3696-3706
    • Saadoun, D.1    Resche-Rigon, M.2    Thibault, V.3    Piette, J.C.4    Cacoub, P.5
  • 10
    • 67349186964 scopus 로고    scopus 로고
    • Critical analysis of rituximab-induced serological changes in connective tissue diseases
    • Cornec D, Avouac J, Youinou P, Saraux A,. Critical analysis of rituximab-induced serological changes in connective tissue diseases. Autoimmunity Rev 2009; 8: 515-9.
    • (2009) Autoimmunity Rev , vol.8 , pp. 515-519
    • Cornec, D.1    Avouac, J.2    Youinou, P.3    Saraux, A.4
  • 11
    • 84857738847 scopus 로고    scopus 로고
    • A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis
    • De Vita S, Quartuccio L, Isola M, Mazzaro C, Scaini P, Lenzi M, et al. A randomized controlled trial of rituximab for the treatment of severe cryoglobulinemic vasculitis. Arthritis Rheum 2012; 64: 847-54.
    • (2012) Arthritis Rheum , vol.64 , pp. 847-854
    • De Vita, S.1    Quartuccio, L.2    Isola, M.3    Mazzaro, C.4    Scaini, P.5    Lenzi, M.6
  • 12
    • 84857705804 scopus 로고    scopus 로고
    • A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis
    • Sneller MC, Hu Z, Langford CA,. A randomized controlled trial of rituximab following failure of antiviral therapy for hepatitis C virus-associated cryoglobulinemic vasculitis. Arthritis Rheum 2012; 64: 835-46.
    • (2012) Arthritis Rheum , vol.64 , pp. 835-846
    • Sneller, M.C.1    Hu, Z.2    Langford, C.A.3
  • 13
    • 0028150660 scopus 로고
    • Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis
    • Luqmani RA, Bacon PA, Moots RJ, Janssen BA, Pall A, Emery P, et al. Birmingham Vasculitis Activity Score (BVAS) in systemic necrotizing vasculitis. Q J Med 1994; 87: 671-8.
    • (1994) Q J Med , vol.87 , pp. 671-678
    • Luqmani, R.A.1    Bacon, P.A.2    Moots, R.J.3    Janssen, B.A.4    Pall, A.5    Emery, P.6
  • 14
    • 39749085148 scopus 로고    scopus 로고
    • Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response
    • Landau DA, Saadoun D, Halfon P, Martinot-Peignoux M, Marcellin P, Fois E, et al. Relapse of hepatitis C virus-associated mixed cryoglobulinemia vasculitis in patients with sustained viral response. Arthritis Rheum 2008; 58: 604-11.
    • (2008) Arthritis Rheum , vol.58 , pp. 604-611
    • Landau, D.A.1    Saadoun, D.2    Halfon, P.3    Martinot-Peignoux, M.4    Marcellin, P.5    Fois, E.6
  • 15
    • 77954869956 scopus 로고    scopus 로고
    • Pegylated interferon-α, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: A long-term study
    • Dammacco F, Tucci FA, Lauletta G, Gatti P, De Re V, Conteduca V, et al. Pegylated interferon-α, ribavirin, and rituximab combined therapy of hepatitis C virus-related mixed cryoglobulinemia: a long-term study. Blood 2010; 116: 343-53.
    • (2010) Blood , vol.116 , pp. 343-353
    • Dammacco, F.1    Tucci, F.A.2    Lauletta, G.3    Gatti, P.4    De Re, V.5    Conteduca, V.6
  • 16
    • 68049110509 scopus 로고    scopus 로고
    • Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: A long-term followup study of thirty-two patients
    • Terrier B, Saadoun D, Sene D, Sallam J, Perard L, Coppere B, et al. Efficacy and tolerability of rituximab with or without PEGylated interferon alfa-2b plus ribavirin in severe hepatitis C virus-related vasculitis: a long-term followup study of thirty-two patients. Arthritis Rheum 2009; 60: 2531-40.
    • (2009) Arthritis Rheum , vol.60 , pp. 2531-2540
    • Terrier, B.1    Saadoun, D.2    Sene, D.3    Sallam, J.4    Perard, L.5    Coppere, B.6
  • 17
    • 77955915180 scopus 로고    scopus 로고
    • Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease
    • Petrarca A, Rigacci L, Caini P, Colagrande S, Romagnoli P, Vizutti F, et al. Safety and efficacy of rituximab in patients with hepatitis C virus-related mixed cryoglobulinemia and severe liver disease. Blood 2010; 116: 335-42.
    • (2010) Blood , vol.116 , pp. 335-342
    • Petrarca, A.1    Rigacci, L.2    Caini, P.3    Colagrande, S.4    Romagnoli, P.5    Vizutti, F.6
  • 18
    • 80855123812 scopus 로고    scopus 로고
    • Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: Results of multicenter cohort study and review of the literature
    • Ferri C, Cacoub P, Mazzaro C, Roccatello D, Scaini P, Sebastiani M, et al. Treatment with rituximab in patients with mixed cryoglobulinemia syndrome: results of multicenter cohort study and review of the literature. Autoimmunity Rev 2011; 11: 48-55.
    • (2011) Autoimmunity Rev , vol.11 , pp. 48-55
    • Ferri, C.1    Cacoub, P.2    Mazzaro, C.3    Roccatello, D.4    Scaini, P.5    Sebastiani, M.6
  • 19
    • 73249120052 scopus 로고    scopus 로고
    • Rituximab may form a complex with IgMκ mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis
    • Sene D, Ghillani-Dalbin P, Amoura Z, Musset L, Cacoub P,. Rituximab may form a complex with IgMκ mixed cryoglobulin and induce severe systemic reactions in patients with hepatitis C virus-induced vasculitis. Arthritis Rheum 2009; 60: 3848-55.
    • (2009) Arthritis Rheum , vol.60 , pp. 3848-3855
    • Sene, D.1    Ghillani-Dalbin, P.2    Amoura, Z.3    Musset, L.4    Cacoub, P.5
  • 20
    • 78649736632 scopus 로고    scopus 로고
    • Surrogate markers of B cell non-Hodgkin's lymphoma in patients with hepatitis C virus-related cryoglobulinemic vasculitis
    • Geri G, Terrier B, Semoun O, Saadoun D, Sene D, Charlotte F, et al. Surrogate markers of B cell non-Hodgkin's lymphoma in patients with hepatitis C virus-related cryoglobulinemic vasculitis. Ann Rheum Dis 2010; 69: 2177-80.
    • (2010) Ann Rheum Dis , vol.69 , pp. 2177-2180
    • Geri, G.1    Terrier, B.2    Semoun, O.3    Saadoun, D.4    Sene, D.5    Charlotte, F.6
  • 21
  • 22
    • 19944429608 scopus 로고    scopus 로고
    • Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: A new entity?
    • Saadoun D, Suarez F, Lefrere F, Valensi F, Mariette X, Aouba A, et al. Splenic lymphoma with villous lymphocytes, associated with type II cryoglobulinemia and HCV infection: a new entity? Blood 2005; 105: 74-6.
    • (2005) Blood , vol.105 , pp. 74-76
    • Saadoun, D.1    Suarez, F.2    Lefrere, F.3    Valensi, F.4    Mariette, X.5    Aouba, A.6
  • 23
    • 1642554816 scopus 로고    scopus 로고
    • Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection
    • Sansonno D, Lauletta G, De Re V, Tucci FA, Gatti P, Racanelli V, et al. Intrahepatic B cell clonal expansions and extrahepatic manifestations of chronic HCV infection. Eur J Immunol 2004; 34: 126-36.
    • (2004) Eur J Immunol , vol.34 , pp. 126-136
    • Sansonno, D.1    Lauletta, G.2    De Re, V.3    Tucci, F.A.4    Gatti, P.5    Racanelli, V.6
  • 25
    • 77954230618 scopus 로고    scopus 로고
    • Detection of WA B cells in hepatitis C virus infection: A potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies
    • Knight GB, Gao L, Gragnani L, Elfahal MM, De Rosa FG, Gordon FD, et al. Detection of WA B cells in hepatitis C virus infection: a potential prognostic marker for cryoglobulinemic vasculitis and B cell malignancies. Arthritis Rheum 2010; 62: 2152-9.
    • (2010) Arthritis Rheum , vol.62 , pp. 2152-2159
    • Knight, G.B.1    Gao, L.2    Gragnani, L.3    Elfahal, M.M.4    De Rosa, F.G.5    Gordon, F.D.6
  • 26
    • 79955374432 scopus 로고    scopus 로고
    • Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement
    • Chen Z, Zhu Y, Ren Y, Tong Y, Hua X, Zhu F, et al. Hepatitis C virus protects human B lymphocytes from Fas-mediated apoptosis via E2-CD81 engagement. PLos One 2011; 6: e18933.
    • (2011) PLos One , vol.6
    • Chen, Z.1    Zhu, Y.2    Ren, Y.3    Tong, Y.4    Hua, X.5    Zhu, F.6
  • 27
    • 0036787033 scopus 로고    scopus 로고
    • Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas
    • Zignego AL, Ferri C, Giannelli F, Giannini C, Caini P, Monti M, et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 2002; 137: 571-80.
    • (2002) Ann Intern Med , vol.137 , pp. 571-580
    • Zignego, A.L.1    Ferri, C.2    Giannelli, F.3    Giannini, C.4    Caini, P.5    Monti, M.6
  • 28
    • 1842479859 scopus 로고    scopus 로고
    • Diagnosis, management, and treatment of hepatitis C
    • Strader DB, Wright T, Thomas DL, Seef LB,. Diagnosis, management, and treatment of hepatitis C. Hepatology 2004; 39: 1147-71.
    • (2004) Hepatology , vol.39 , pp. 1147-1171
    • Strader, D.B.1    Wright, T.2    Thomas, D.L.3    Seef, L.B.4
  • 29
    • 77955857269 scopus 로고    scopus 로고
    • Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C-related mixed cryoglobulinemia
    • Saadoun D, Rigon MR, Sene D, Terrier B, Karras A, Perard L, et al. Rituximab plus Peg-interferon-α/ribavirin compared with Peg-interferon-α/ribavirin in hepatitis C-related mixed cryoglobulinemia. Blood 2010; 116: 326-34.
    • (2010) Blood , vol.116 , pp. 326-334
    • Saadoun, D.1    Rigon, M.R.2    Sene, D.3    Terrier, B.4    Karras, A.5    Perard, L.6
  • 30
    • 80053339008 scopus 로고    scopus 로고
    • An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases
    • Ghany MG, Nelson DR, Strader DB, Thomas DL, Seef LB,. An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases. Hepatology 2011; 54: 1433-44.
    • (2011) Hepatology , vol.54 , pp. 1433-1444
    • Ghany, M.G.1    Nelson, D.R.2    Strader, D.B.3    Thomas, D.L.4    Seef, L.B.5


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.